BioSpace News Archive

Deals

GENFIT Seeks $132 Million IPO to Support NASH Programs

France-based GenFit launched its $132 million initial public offering plans in order to raise funds that will be used to support the Phase III trial and planned commercialization of its elafibranor compound for non-alcoholic steatohepatitis (NASH).

March 15, 2019
·
3 min read
·
Alex Keown
Drug Development

Researchers Use Pfizer’s Anti-Smoking Drug Chantix to Control Neurons

The research has broad potential for targeted treatments for neurological diseases like epilepsy or for pain treatment. Their research was published in the journal Science.

March 15, 2019
·
3 min read
·
Mark Terry
Business

New Theranos Documentary Hits the Silver Screens, Then HBO

Elizabeth Holmes, the founder of the now-failed Theranos, has become a subject of fascination for many people. Her ability to secure billions of dollars for her company without showing any supporting evidence of the product to investors is a compelling study.

March 15, 2019
·
3 min read
·
Alex Keown
Policy

Azar on the Hot Seat Over the President’s Proposed Slash of NIH Funding

The White House budget proposal released earlier this week that slashed spending on the National Institutes of Health and Medicare programs has put members of the administration, including Health and Human Services Secretary Alex Azar on the defensive.

March 15, 2019
·
3 min read
·
Alex Keown
Policy

Tip That Launched College Bribery Scandal Case Came From Pharma Pump-and-Dump Investigation

The scandal, dubbed Operation Varsity Blues, revolves around dozens of wealthy parents paying a college consultant to help cheat on entrance exams and falsify student athlete profiles, as well as bribing coaches at a number of prestigious universities.

March 15, 2019
·
3 min read
·
Mark Terry
Business

Outgoing FDA Commissioner Gottlieb Criticizes Pharma for Resisting Change

During his relatively brief tenure as Commissioner of the U.S. Food and Drug Administration (FDA), Scott Gottlieb has worked to streamline and advance guidelines for clinical trials. As something of a parting shot, Gottlieb made a statement criticizing the industry’s reluctance to take advantage of them.

March 15, 2019
·
3 min read
·
Mark Terry
FDA

FDA Action Alert: Sage, Jazz, Lexicon and Sanofi, AMAG Pharma, and Recro Pharma

It’s a busy week for the U.S. Food and Drug Administration (FDA) with quite a number of pending drug approvals, several of which were delayed for a variety of reasons. Here’s a look.

March 15, 2019
·
4 min read
·
Mark Terry
Career Advice

A Career Conversation With the Accidental Medical Writer

Are you familiar with the medical writing profession? If not, you could be missing out on one of the most flexible and rewarding careers in life sciences.

March 15, 2019
·
4 min read
·
Porschia Parker